Filing Details
- Accession Number:
- 0001209191-18-036794
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-08 19:37:04
- Reporting Period:
- 2018-06-08
- Accepted Time:
- 2018-06-08 19:37:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1029142 | Dynavax Technologies Corp | DVAX | Pharmaceutical Preparations (2834) | 330728374 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1226066 | S Michael Ostrach | C/O Dynavax Technologies 2929 Seventh Street, Suite 100 Berkeley CA 94710 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-06-08 | 25,056 | $15.52 | 80,554 | No | 4 | F | Direct | |
Common Stock | Disposition | 2018-06-08 | 4,000 | $15.53 | 76,554 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- The reporting person is reporting the sale of 25,056 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with thedelivery of common stock to the reporting person on June 8, 2018.